Nikola Bangemann Selected Research

Nikola Bangemann Research Topics

7	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2007
5	Neoplasms (Cancer) 01/2018 - 01/2011
3	Neoplasm Metastasis (Metastasis) 01/2015 - 01/2011
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Stroke (Strokes) 01/2022
1	Infections 01/2018
1	Body Weight (Weight, Body) 08/2007

1	Neurofilament ProteinsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Gemcitabine FDA Link 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 03/2016
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Conditioned Culture MediaIBA 01/2015
1	CytokinesIBA 01/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	ChemokinesIBA 01/2015
1	Cytostatic AgentsIBA 01/2014
1	Estrogen ReceptorsIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 02/2012
1	AcyltransferasesIBA 02/2012
1	EnzymesIBA 02/2012
1	Hormones (Hormone)IBA 02/2012
1	LipidsIBA 02/2012
1	Phosphatidylcholines (Phosphatidylcholine)IBA 02/2012
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2012
1	Triglycerides (Triacylglycerol)IBA 02/2012
1	taxaneIBA 08/2007
1	CarbamatesIBA 08/2007
1	AnthracyclinesIBA 08/2007
1	Monoclonal AntibodiesIBA 08/2007
1	Capecitabine (Xeloda)FDA Link 08/2007
1	Trastuzumab (Herceptin)FDA Link 08/2007
1	Taxoids (Taxanes)IBA 08/2007
1	human ERBB2 proteinIBA 08/2007